ObjectiveThe objective was to report a case of experienced psychosis during the treatment with methylphenidate (MPH) in a cocaine-dependent adult treated for attention-deficit/hyperactivity disorder (ADHD) with comorbid cocaine dependence.ConclusionADHD is a frequent comorbidity in substance use disorder (SUD) patients. MPH may be effective in treating ADHD symptoms in SUD patients, thus preventing possible adverse outcomes. Cocaine-induced psychosis may be a risk factor for development of psychosis in the presence of a concurrent treatment with MPH.<br/
We report on a unique clinical case of psychosis precipitated by Attention Deficit Hyperactivity Dis...
To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients with an...
Objective. This is a review of the current treatments used to alleviate the psychotic symptoms assoc...
Cocaine use disorder (CUD) is a public health concern and no effective pharmacotherapy has been demo...
Methylphenidate (MPH) is commonly prescribed for attention deficit hyperactivity disorder (ADHD). Re...
Introduction: Concomitant drug use is common among opioid-dependent patients in maintenance therapy....
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (...
A transition in viewing mental disorders from conditions defined as a set of unique characteristics ...
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (...
Methylphenidate (MPH) occupies brain striatal dopamine transporters (DATs) and is an effective treat...
Objective: Chronic methamphetamine use is commonly associated with the development of psychotic symp...
Background: Cocaine use disorder (CUD) is a growing public health concern, but so far no effective p...
Objective: The objective of this study was to determine the risk of lifetime and current methampheta...
Background: Adult attention-deficit/hyperactivity disorder (ADHD) is associated with high comorbidit...
Attention-deficit/hyperactivity disorder (ADHD) is highly comorbid with substance use disorders, par...
We report on a unique clinical case of psychosis precipitated by Attention Deficit Hyperactivity Dis...
To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients with an...
Objective. This is a review of the current treatments used to alleviate the psychotic symptoms assoc...
Cocaine use disorder (CUD) is a public health concern and no effective pharmacotherapy has been demo...
Methylphenidate (MPH) is commonly prescribed for attention deficit hyperactivity disorder (ADHD). Re...
Introduction: Concomitant drug use is common among opioid-dependent patients in maintenance therapy....
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (...
A transition in viewing mental disorders from conditions defined as a set of unique characteristics ...
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (...
Methylphenidate (MPH) occupies brain striatal dopamine transporters (DATs) and is an effective treat...
Objective: Chronic methamphetamine use is commonly associated with the development of psychotic symp...
Background: Cocaine use disorder (CUD) is a growing public health concern, but so far no effective p...
Objective: The objective of this study was to determine the risk of lifetime and current methampheta...
Background: Adult attention-deficit/hyperactivity disorder (ADHD) is associated with high comorbidit...
Attention-deficit/hyperactivity disorder (ADHD) is highly comorbid with substance use disorders, par...
We report on a unique clinical case of psychosis precipitated by Attention Deficit Hyperactivity Dis...
To determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients with an...
Objective. This is a review of the current treatments used to alleviate the psychotic symptoms assoc...